About Asuragen
Asuragen is a company based in Austin (United States) founded in 2006 was acquired by Bio-Techne in March 2021.. Asuragen has raised $80 million across 23 funding rounds from investors including Bio-Techne, HHS and PTV Healthcare Capital. Asuragen operates in a competitive market with competitors including Guardant Health, Abcam, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Austin, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asuragen, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$80 M (USD)
in 23 rounds
-
Latest Funding Round
$182.39 K (USD), Grant
Sep 30, 2019
-
Investors
Bio-Techne
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Bio-Techne
(Mar 03, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
92 people
Sales and Marketing
76 people
Leadership Team
40 people
Product Management Team
35 people
Senior Team
31 people
Finance and Accounting
20 people
Human Resources and Administration
18 people
Advanced Team
13 people
Unlock access to complete
Funding Insights of Asuragen
Asuragen has successfully raised a total of $80M across 23 strategic funding rounds. The most recent funding activity was a Grant round of $182.39 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Grant — $182,393
-
First Round
First Round
(01 Jun 2006)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Grant - Asuragen | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - Asuragen | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - Asuragen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asuragen
Asuragen has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Bio-Techne, HHS and PTV Healthcare Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in expansion & late stage start-ups in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asuragen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asuragen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asuragen Comparisons
Competitors of Asuragen
Asuragen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Abcam, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asuragen
Frequently Asked Questions about Asuragen
When was Asuragen founded?
Asuragen was founded in 2006.
Where is Asuragen located?
Asuragen is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Is Asuragen a funded company?
Asuragen is a funded company, having raised a total of $80M across 23 funding rounds to date. The company's 1st funding round was a Grant of $229.47K, raised on Jun 01, 2006.
What does Asuragen do?
Asuragen was founded in 2006 in Austin, United States, as a provider of molecular diagnostics in genetics and oncology. Kits for genetic sequencing and cancer monitoring are offered, including AmplideX reagents for FMR1 gene analysis and Quantidex products for lung cancer and chronic myeloid leukemia quantification. FDA clearance has been obtained for several products, supporting research and clinical applications in the sector.
Who are the top competitors of Asuragen?
Asuragen's top competitors include Guardant Health, Abcam and Foundation Medicine.
Who are Asuragen's investors?
Asuragen has 5 investors. Key investors include Bio-Techne, HHS, PTV Healthcare Capital, Telegraph Hill Partners, and Growth Capital Fund.